 | • レポートコード：MRC23Q36343 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のサケ中毒治療薬市場について調査・分析し、世界のサケ中毒治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口、注射）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Zoetis、Merck Animal Health、Merial、Elanco Animal Health、Bayer HealthCare Animal Health、Boehringer Ingelheim Animal Health、Novartis Animal Health、Virbac Group、Savavet、ECO Animal Healthなどが含まれています。 世界のサケ中毒治療薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、サケ中毒治療薬市場規模を推定する際に考慮しました。本レポートは、サケ中毒治療薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、サケ中毒治療薬に関するビジネス上の意思決定に役立てることを目的としています。 ・サケ中毒治療薬市場の概要 - サケ中毒治療薬のタイプ別セグメント - 世界のサケ中毒治療薬市場規模：タイプ別分析（経口、注射） - サケ中毒治療薬の用途別セグメント - 世界のサケ中毒治療薬市場規模：用途別分析（病院、クリニック、その他） - 世界のサケ中毒治療薬市場規模予測（2018年-2029年） ・サケ中毒治療薬市場の成長トレンド - サケ中毒治療薬の地域別市場規模（2018年-2029年） - サケ中毒治療薬市場ダイナミクス - サケ中毒治療薬の業界動向 - サケ中毒治療薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：経口、注射 - 世界のサケ中毒治療薬のタイプ別市場規模（2018年-2023年） - 世界のサケ中毒治療薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界のサケ中毒治療薬の用途別市場規模（2018年-2023年） - 世界のサケ中毒治療薬の用途別市場規模（2024年-2029年） ・サケ中毒治療薬の地域別市場規模 - 北米のサケ中毒治療薬市場規模（2018年-2029年） - アメリカのサケ中毒治療薬市場規模（2018年-2029年） - ヨーロッパのサケ中毒治療薬市場規模（2018年-2029年） - アジア太平洋のサケ中毒治療薬市場規模（2018年-2029年） - 中国のサケ中毒治療薬市場規模（2018年-2029年） - 日本のサケ中毒治療薬市場規模（2018年-2029年） - 韓国のサケ中毒治療薬市場規模（2018年-2029年） - インドのサケ中毒治療薬市場規模（2018年-2029年） - オーストラリアのサケ中毒治療薬市場規模（2018年-2029年） - 中南米のサケ中毒治療薬市場規模（2018年-2029年） - 中東・アフリカのサケ中毒治療薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Zoetis、Merck Animal Health、Merial、Elanco Animal Health、Bayer HealthCare Animal Health、Boehringer Ingelheim Animal Health、Novartis Animal Health、Virbac Group、Savavet、ECO Animal Health ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Salmon Poisoning Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Salmon Poisoning Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Salmon Poisoning Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Salmon Poisoning Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Salmon Poisoning Therapeutics include Zoetis, Merck Animal Health, Merial, Elanco Animal Health, Bayer HealthCare Animal Health, Boehringer Ingelheim Animal Health, Novartis Animal Health, Virbac Group and Savavet, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Salmon Poisoning Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Salmon Poisoning Therapeutics.
The Salmon Poisoning Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Salmon Poisoning Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Salmon Poisoning Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zoetis
Merck Animal Health
Merial
Elanco Animal Health
Bayer HealthCare Animal Health
Boehringer Ingelheim Animal Health
Novartis Animal Health
Virbac Group
Savavet
ECO Animal Health
Segment by Type
Oral
Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Salmon Poisoning Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Salmon Poisoning Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Salmon Poisoning Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Salmon Poisoning Therapeutics Market Perspective (2018-2029)
2.2 Salmon Poisoning Therapeutics Growth Trends by Region
2.2.1 Global Salmon Poisoning Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Salmon Poisoning Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Salmon Poisoning Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Salmon Poisoning Therapeutics Market Dynamics
2.3.1 Salmon Poisoning Therapeutics Industry Trends
2.3.2 Salmon Poisoning Therapeutics Market Drivers
2.3.3 Salmon Poisoning Therapeutics Market Challenges
2.3.4 Salmon Poisoning Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Salmon Poisoning Therapeutics Players by Revenue
3.1.1 Global Top Salmon Poisoning Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Salmon Poisoning Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Salmon Poisoning Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Salmon Poisoning Therapeutics Revenue
3.4 Global Salmon Poisoning Therapeutics Market Concentration Ratio
3.4.1 Global Salmon Poisoning Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Salmon Poisoning Therapeutics Revenue in 2022
3.5 Salmon Poisoning Therapeutics Key Players Head office and Area Served
3.6 Key Players Salmon Poisoning Therapeutics Product Solution and Service
3.7 Date of Enter into Salmon Poisoning Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Salmon Poisoning Therapeutics Breakdown Data by Type
4.1 Global Salmon Poisoning Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Salmon Poisoning Therapeutics Forecasted Market Size by Type (2024-2029)
5 Salmon Poisoning Therapeutics Breakdown Data by Application
5.1 Global Salmon Poisoning Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Salmon Poisoning Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Salmon Poisoning Therapeutics Market Size (2018-2029)
6.2 North America Salmon Poisoning Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Salmon Poisoning Therapeutics Market Size by Country (2018-2023)
6.4 North America Salmon Poisoning Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Salmon Poisoning Therapeutics Market Size (2018-2029)
7.2 Europe Salmon Poisoning Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Salmon Poisoning Therapeutics Market Size by Country (2018-2023)
7.4 Europe Salmon Poisoning Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Salmon Poisoning Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Salmon Poisoning Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Salmon Poisoning Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Salmon Poisoning Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Salmon Poisoning Therapeutics Market Size (2018-2029)
9.2 Latin America Salmon Poisoning Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Salmon Poisoning Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Salmon Poisoning Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Salmon Poisoning Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Salmon Poisoning Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Salmon Poisoning Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Salmon Poisoning Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Salmon Poisoning Therapeutics Introduction
11.1.4 Zoetis Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.1.5 Zoetis Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Detail
11.2.2 Merck Animal Health Business Overview
11.2.3 Merck Animal Health Salmon Poisoning Therapeutics Introduction
11.2.4 Merck Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.2.5 Merck Animal Health Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Salmon Poisoning Therapeutics Introduction
11.3.4 Merial Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.3.5 Merial Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Salmon Poisoning Therapeutics Introduction
11.4.4 Elanco Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer HealthCare Animal Health
11.5.1 Bayer HealthCare Animal Health Company Detail
11.5.2 Bayer HealthCare Animal Health Business Overview
11.5.3 Bayer HealthCare Animal Health Salmon Poisoning Therapeutics Introduction
11.5.4 Bayer HealthCare Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.5.5 Bayer HealthCare Animal Health Recent Development
11.6 Boehringer Ingelheim Animal Health
11.6.1 Boehringer Ingelheim Animal Health Company Detail
11.6.2 Boehringer Ingelheim Animal Health Business Overview
11.6.3 Boehringer Ingelheim Animal Health Salmon Poisoning Therapeutics Introduction
11.6.4 Boehringer Ingelheim Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.6.5 Boehringer Ingelheim Animal Health Recent Development
11.7 Novartis Animal Health
11.7.1 Novartis Animal Health Company Detail
11.7.2 Novartis Animal Health Business Overview
11.7.3 Novartis Animal Health Salmon Poisoning Therapeutics Introduction
11.7.4 Novartis Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.7.5 Novartis Animal Health Recent Development
11.8 Virbac Group
11.8.1 Virbac Group Company Detail
11.8.2 Virbac Group Business Overview
11.8.3 Virbac Group Salmon Poisoning Therapeutics Introduction
11.8.4 Virbac Group Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.8.5 Virbac Group Recent Development
11.9 Savavet
11.9.1 Savavet Company Detail
11.9.2 Savavet Business Overview
11.9.3 Savavet Salmon Poisoning Therapeutics Introduction
11.9.4 Savavet Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.9.5 Savavet Recent Development
11.10 ECO Animal Health
11.10.1 ECO Animal Health Company Detail
11.10.2 ECO Animal Health Business Overview
11.10.3 ECO Animal Health Salmon Poisoning Therapeutics Introduction
11.10.4 ECO Animal Health Revenue in Salmon Poisoning Therapeutics Business (2018-2023)
11.10.5 ECO Animal Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details